250 articles across injectables, lasers, body contouring, skin therapeutics, and provider safety.
Women lose up to 30% of skin collagen in the first five postmenopausal years. Reviews the evidence on HRT, biostimulators, skin boosters, and energy devices for…
Morpheus8 can reach subcutaneous fat at deeper settings. The FDA's 2025 RF microneedling alert flagged fat loss, burns, and nerve damage. Covers vulnerable facial zones…
Frozen Botox is not a product problem — it is a dosing and technique problem. Anatomy, injection patterns, unit counts, microdosing philosophy, and what to ask a…
Ultherapy is the only device FDA-cleared to lift. Thermage tightens. RF microneedling remodels texture. Lasers smooth surface. None repositions tissue like a surgical…
Vbeam (595 nm PDL) and Excel V (532/1064 nm KTP/Nd:YAG) are the dominant vascular laser platforms. How they compare on mechanism, evidence, comfort, purpura risk, and…
PRP has decades of evidence. Exosomes have zero FDA approvals. PDRN sits between them. Head-to-head on mechanism, evidence, regulation, and realistic expectations for…
PicoSure (755 nm) and PicoWay (532/1064/785 nm) are the dominant picosecond laser platforms. The choice depends on ink color, skin type, and whether the target is…
PIH is the most common pigment complication after lasers, peels, microneedling, and injectables in skin of color. What the evidence says about prevention, early…
The FDA's October 2025 RF microneedling safety communication: what the warning says, which devices are cleared, the reported risks, and the questions every patient…
Rosacea in Fitzpatrick IV-VI is often missed because erythema is harder to see. Learn safer diagnosis and treatment choices, including why 1064 nm Nd:YAG is usually…